Personalis’ NeXT Personal® test shows promise in predicting cervical cancer recurrence risk. The innovative test aims to detect small traces of ctDNA, monitor response to therapy, and predict clinical outcomes. This groundbreaking analysis presented at ASCO highlights the potential of NeXT Personal to impact cancer care and management, offering early detection and personalized treatment strategies. […]